Netherlands funds TB research

At the World Conference on Lung Health Nov. 2, the Dutch Ministry of Foreign Affairs announced a $38.3 million investment in three partnerships working to develop drugs and vaccines to fight tuberculosis.

The commitment is the largest investment a single country has made in research of the illness to date.

Aeras Global TB Vaccine Foundation will receive $23.5 million for preclinical work and clinical trials of vaccine candidates.

The Global Alliance for TB Drug Development will get $10.2 million to expand drug discovery projects, develop tools for clinical work and increase efforts globally for the introduction of new drug regimens.

The Foundation for Innovative New Diagnostics will receive $5.1 million for the development of diagnostic tests.

Billed as the second-deadliest infectious disease behind AIDS, tuberculosis kills nearly 2 million people each year.

Leave a Response

Your email address will not be published. All fields are required.